Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis
- 80 Downloads
Compliance with ethical standards
Conflict of interest
Niels Teich and Andreas Stallmach received advisory and lecture fees from Janssen.
The present paper was exempt from approval.
Informed consent was obtained from the individual participant included in the study.
- 4.Bär F, Dietrich NA, Krause Tet al; German IBD Study Group (2018) Vedolizumab in the treatment of chronic, antibiotic dependent or refractory Pouchitis. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.14479
© Springer International Publishing AG, part of Springer Nature 2018